Oligoden droglioma (OG) marker MAP2 (microtubuleassociated protein 2) protein and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- FUDAN UNIV
- Publication Date
- 2012-04-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of biotechnology and medicine. It relates to markers of human oligodendroglioma, in particular to a human oligodendroglioma (Oligoden droglioma) capable of distinguishing clinically chemotherapy-sensitive, 1p allele heterozygous loss (1p Loss of heterozygosity, 1p LOH) , OG) protein marker MAP2 protein (microtubulea associated protein 2, MAP2) and its use. Background technique
[0002] Biomarkers refer to physical, chemical, or biological indicators that can be objectively measured, indicating normal physiological or pathological processes, or the body's response to drugs. One of the most critical issues in modern tumor research is to find markers for early detection, diagnostic typing, treatment monitoring and prognosis, and drug targets. Studies have revealed a series of changes in the intracellular protein expression profile during the transition from a normal state to a tumor. Tumor markers are a class of subs...